The Effect of Formulation, Process, and Method Variables on the Reconstitution Time in Dual Chamber Syringes

Reference

1. 1.↵
   1. Borlet M.

   Financial Model for Converting from a Vial to a Pre-filled Syringe. In The Universe of Pre-Filled Syringes and Injection Devices; PDA: San Diego, CA, 2008.
2. 2.↵
   1. Harrison B.,
   2. Rios M.

   Big Shot: Developments in Prefilled Syringes. Pharm. Technol. 2007, 31, 50–60.

   OpenUrl
3. 3.↵
   1. Michaels T. M. Jr..

   Dual Chamber Prefill Syringes. J. Parenter. Sci. Technol. 1988, 42 (6), 199–202.

   OpenUrlPubMed
4. 4.↵
   1. Werk T.,
   2. Ludwig I. S.,
   3. Luemkemann J.,
   4. Huwyler J.,
   5. Mahler H.-C.,
   6. Hafner M.

   Technology, Applications and Process Challenges of Dual Chamber Systems. J. Pharm. Sci. 2016, 105 (1), 4–9.

   OpenUrlPubMed
5. 5.↵
   1. Cao W.,
   2. Krishnan S.,
   3. Ricci M. S.,
   4. Shih L. Y.,
   5. Liu D.,
   6. Gu J. H.,
   7. Jameel F.

   Rational Design of Lyophilized High Concentration Protein Formulations—Mitigating the Challenge of Slow Reconstitution with Multidisciplinary Strategies. Eur. J. Pharm. Biopharm. 2013, 85 (2), 287–293.

   OpenUrl
6. 6.↵
   1. Bogner R.,
   2. Bhatnagar B.,
   3. Tchessalov S.

   Reconstitution of Highly Concentrated Lyophilized Proteins. In CPPR—Freeze Drying of Pharmaceuticals & Biologicals; Beaver Run Resort: Breckenridge, CO, 2012.
7. 7.↵
   1. Shire S. J.,
   2. Shahrokh Z.,
   3. Liu J.

   Challenges in the Development of High Protein Concentration Formulations. J. Pharm. Sci. 2004, 93 (6), 1390–1402.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Liu J.,
   2. Nguyen M. D.,
   3. Andya J. D.,
   4. Shire S. J.

   Reversible Self-association Increases the Viscosity of a Concentrated Monoclonal Antibody in Aqueous Solution. J. Pharm. Sci. 2005, 94 (9) 1928–1940.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Lin L.-F. H.,
   2. Bunnell R.

   Overcoming Challenges in the Reconstitution of a High-Concentration Protein Drug Product. BioPharm International 2013, 26 (3), 28–39.

   OpenUrl
10. 10.↵
    1. Schersch K.,
    2. Betz O.,
    3. Garidel P.,
    4. Muehlau S.,
    5. Bassarab S.,
    6. Winter G.

    Systematic Investigation of the Effect of Lyophilizate Collapse on Pharmaceutically Relevant Proteins I: Stability after Freeze-drying. J. Pharm. Sci. 2010, 99 (5) 2256–2278.

    OpenUrlPubMed
11. 11.↵
    1. Tsourouflis S.,
    2. Flink J. M.,
    3. Karel M.

    Loss of Structure in Freeze-dried Carbohydrates Solutions: Effect of Temperature, Moisture Content and Composition. J. Sci. Food Agric. 1976, 27 (6) 509–519.

    OpenUrl
12. 12.↵
    1. Lewis L.,
    2. Johnson R.,
    3. Oldroyd M.,
    4. Ahmed S.,
    5. Joseph L.,
    6. Saracovan I.,
    7. Sinha S.

    Characterizing the Freeze-drying Behavior of Model Protein Formulations. AAPS PharmSci Tech 2010, 11 (4) 1580–1590.

    OpenUrl
13. 13.↵
    1. Quraishi S. A.,
    2. Orkin F. K.,
    3. Murray W. B.

    Dantrolene Reconstitution: Can Warmed Diluent Make a Difference? J. Clin. Anesthesia 2006, 18 (5) 339–342.

    OpenUrlPubMed
14. 14.↵
    1. Mitchell L. W.,
    2. Leighton B. L.

    Warmed Diluent Speeds Dantrolene Reconstitution. Canadian J. Anaesthesia 2003, 50 (2) 127–130.

    OpenUrl
15. 15.↵
    1. Werk T.,
    2. Huwyler J.,
    3. Hafner M.,
    4. Luemkemann J.,
    5. Mahler H. C.

    An Impedance-Based Method To Determine Reconstitution Time for Freeze-dried Pharmaceuticals. J. Pharm. Sci. 2015, 104 (9) 2948–2955.

    OpenUrl
16. 16.↵
    1. Werk T.,
    2. Luemkemann J.,
    3. Steiner R.,
    4. Rietmann R.

    Method for Determining Whether Reconstitution of a Solution in a Container Is Completed. Eur. Patent Application, 2014.
17. 17.↵
    1. Werk T.,
    2. Ludwig I. S.,
    3. Luemkemann J.,
    4. Mahler H.-C.,
    5. Huwyler J.,
    6. Haeuser C.,
    7. Hafner M.

    New Processes for Freeze-drying in Dual-Chamber Systems. PDA J. Pharm. Sci. Technol. 2016, 70 (3), 191–207.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Werk T.,
    2. Luemkemann J.,
    3. Mahler H.-C.

    Preparing a Double Chamber Container. Eur. Patent Application 14196466.8, 2014.
19. 19.↵
    1. Werk T.,
    2. Luemkemann J.,
    3. Schneider S.,
    4. Voelkle J.,
    5. Mahler H.-C.

    Method for Providing in a Primary Packaging Container a Dried Solid Product Containing an Active Pharmaceutical Ingredient. Eur. Patent Application 14189063.2, 2014.
20. 20.↵
    1. Werk T.,
    2. Ludwig I. S.,
    3. Luemkemann J.,
    4. Huwyler J.,
    5. Mahler H.-C.,
    6. Haeuser C.,
    7. Hafner M.

    New Processes for Freeze-Drying in Dual chamber Systems. Unpublished manuscript, 2015.
21. 21.↵
    1. Lam P.,
    2. Patapoff T. W.

    An Improved Method for Visualizing the Morphology of Lyophilized Product Cakes. PDA J. Pharm. Sci. Technol. 2011, 65 (4) 425–430.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Ricci M.,
    2. Franzier M.,
    3. Moore J.,
    4. Cromwell M.,
    5. Galush W. J.,
    6. Patel A. R.,
    7. Adler M.,
    8. Altenburger U.,
    9. Grauschopf U.,
    10. Goldbach P.,
    11. Fast J. L.,
    12. Kraemer I.,
    13. Mahler H.-C.

    In-use Stability of Biological Parenteral Products: Aspects of Physicochemical and Microbiological Stability after Container Penetration, Reconstitution, Dilution and Holding Time. AJHP 2015, 72 (5), 396–407.

    OpenUrl